Literature DB >> 2372672

Comparison of morphometry and DNA flow cytometry with standard prognostic factors in bladder cancer.

P K Lipponen1, Y Collan, M J Eskelinen, E Pesonen, M Sotarauta, S Nordling.   

Abstract

In 83 bladder cancer patients with adequate follow-up (mean 13 years, range 9-22) the prognostic value of morphometric, DNA flow cytometric and clinical parameters was assessed. Paraffin embedded material was used in flow cytometry. Univariate life-table analysis showed the statistically significant relation of clinical stage, histological grade, mean nuclear area, the Standard Deviation (SD) of nuclear area, mean maximal nuclear diameter, mean nuclear perimeter and the volume corrected mitotic index (M/V index) to survival when bladder cancer deaths alone were used in the analysis. The recurrence of bladder cancer could be predicted with the M/V index. Survival analysis with Cox's regression model pointed to primary tumour clinical stage as the most important prognostic factor of crude survival. Histologically, grade and the SD of nuclear area were the best prognostic factors. Primary tumour stage and histological grade were the best predictors of death from bladder cancer. In Cox's model, histoquantitative methods are almost as good as clinical staging in predicting prognosis. DNA flow cytometry of paraffin embedded material offered no advantage over clinical stage, histological grade or morphology in assessing prognosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2372672     DOI: 10.1111/j.1464-410x.1990.tb14826.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  5 in total

1.  Improved objectivity of grading of T(A,1) transitional cell carcinomas of the urinary bladder by quantitative nuclear and proliferation related features.

Authors:  M G Bol; J P Baak; P C de Bruin; S Rep; W Marx; S Bos; O Kisman
Journal:  J Clin Pathol       Date:  2001-11       Impact factor: 3.411

2.  The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification.

Authors:  J C Angulo; J I Lopez; N Flores; J D Toledo
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

3.  Proliferation markers and DNA content analysis in urinary bladder TaT1 urothelial cell carcinomas: identification of subgroups with low and high stage progression risks.

Authors:  M G W Bol; J P A Baak; B van Diermen; S Buhr-Wildhagen; E A M Janssen; K H Kjellevold; A J Kruse; O Mestad; P Øgreid
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

4.  Determination of DNA ploidy and ABH antigen reactivity in both frozen and formalin-fixed bladder tumor tissue.

Authors:  P U Malmström; J Vasko; K Wester; C Busch
Journal:  Urol Res       Date:  1991

5.  Selection of patients for intravesical therapy for superficial bladder cancer.

Authors:  Y Bedük; L S Yaman; S Baltaci; Y Z Müftüoğlu; T Yurdakul; O Göğüş
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.